NY-ULTIVUE
7.4.2022 16:02:08 CEST | Business Wire | Press release
Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige , the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate on the co-development and co-marketing of AI-powered spatial immunophenotype capabilities to pharmaceutical and research customers.
Collaborative efforts will initially focus on the development of AI to enable improved understanding of the tumor microenvironment and support the interpretation of Ultivue’s novel multiplex immunofluorescence (mIF) immuno-oncology biomarker panels.
The Paige portfolio includes the Paige Platform, a comprehensive imaging solution composed of the FDA-cleared and CE-marked FullFocus™, an intuitive and responsive viewer for pathology scans that supports primary diagnosis together with a data management solution for storage of pathology scans. The fast, zero-footprint, scanner-agnostic viewer, storage capabilities and AI-based diagnostic software help pathologists review cases and support their overall workflow.
Ultivue, a leader in advancing precision medicine solutions by accelerating tissue biomarker discovery and validation, develops unique platform agnostic solutions for use in both mIF imaging and spatial phenomics. Its proprietary InSituPlex® technology, designed for fast and comprehensive exploration of biologically relevant targets, up to 12-plex, with same slide-H&E analysis in precious tissue samples combines the power of computational pathology & spatial biology to guide translational science in immuno-oncology.
“This collaboration with Paige is an exciting milestone for Ultivue as we consider the evolving impact of AI and deep learning tools on histopathological images in clinical settings,” said Jacques Corriveau, CEO, Ultivue. “Importantly, our aligned goals are to facilitate the decentralization and democratization of the generation and analysis of complex spatial data.”
“The combination of Ultivue’s robust biomarker detection capabilities and Paige’s AI-enabled computational pathology technology allows us to deliver new products that will elevate how immuno-oncology research is done today,” said David Klimstra, M.D., Founder and Chief Medical Officer at Paige. “By uniting two platform-agnostic technologies, we are well-positioned to enable broad adoption of our AI-powered biomarker imaging solutions.”
About Paige
Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., David Klimstra, M.D., and colleagues from Memorial Sloan Kettering Cancer Center (MSK). The company builds computational pathology products designed so patients and their care teams can make effective, more informed treatment decisions. With this new class of AI-based technologies positioned to drive the future of diagnostics, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s products deliver insights to pathologists and oncologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA approval for an AI-based digital pathology product. For additional information, please visit: paige.ai , Twitter and LinkedIn .
About Ultivue
Ultivue provides researchers in translational medicine with multiplex biomarker assays for tissue phenotyping and digital pathology. Its proprietary InSituPlex technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions and scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs. Learn more at ultivue.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220407005283/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TestGorilla Launches New AI Readiness and AI Fluency Assessments to Help Companies Hire for the Skills That Matter Now3.3.2026 11:34:00 CET | Press release
Seven new AI assessments, built on TestGorilla's five-pillar AI Fluency Framework, give hiring teams a science-backed way to evaluate what resumes can no longer reveal. TestGorilla, the skills-based hiring platform trusted by thousands of organisations worldwide, today announced a suite of new assessments and simulation tests purpose-built to help talent acquisition teams evaluate AI readiness and AI fluency off the back of the company’s flagship event: Hire for the AI Era. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303398545/en/ Use validated assessments and structured AI video interviews through the TestGorilla platform to measure different aspects of AI fluency across technical and non-technical roles. Inside the platform, tools are clearly labeled with AI fluency making it easy to find and build an assessment. The launch coincides with a crucial shift in the hiring landscape. TestGorilla co-founder and CEO Wouter
Lucidis® Sets High Standards in Premium Cataract Surgery with Full-Range Vision Performance3.3.2026 11:19:00 CET | Press release
Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening its position as a disruptive solution in premium cataract surgery. Unlike traditional Extended Depth of Focus lenses, Lucidis® delivers full-range visual performance comparable to a premium trifocal IOL - while preserving contrast sensitivity, visual quality, and minimizing side effects such as halos and glare, hallmarks of its patented fully refractive design. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303823337/en/ Swiss Advanced Vision premium IOL lenses for cataract surgery A recent peer-reviewed study, Comparative Analysis of Visual Outcomes Between Lucidis 108M (EDOF) and PhysIOL BVI FineVision (Diffractive) IOLs Using Defocus Curve Measurements by H. Naftali, W. Nasser, and M. Naftali, provides compelling comparative data. The findings show that Lucidis® achieves a d
Türk Telekom and P.I. Works Announce Strategic Collaboration on AI-Driven 5G Network Slicing at MWC Barcelona3.3.2026 10:16:00 CET | Press release
Türk Telekom and P.I. Works today announced a strategic collaboration on AI-driven 5G network slicing assurance, unveiled during GSMA Mobile World Congress (MWC) Barcelona 2026. Türk Telekom has successfully trialed P.I. Works’ AI-powered 5G RAN Slice Assurance solution in Türk Telekom R&D Innovation & Test Center, strengthening its ability to deliver differentiated and performance-assured 5G services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303543772/en/ The solution is designed to ensure network slicing performance by enabling real-time monitoring of slice-level KPIs, early detection of performance degradations, and AI-assisted root cause analysis. With these capabilities, Türk Telekom aims to proactively manage service levels, and ensure consistent service continuity across different 5G slice types. Türk Telekom Ebubekir Şahin stated: “As we approach the 5G era, we continuously evolve our mobile network to deliv
BlackLine Brings BeyondTheBlack to Paris, Showcasing Innovation and Best Practice for Modern Finance Teams3.3.2026 10:00:00 CET | Press release
BlackLine, Inc. (Nasdaq: BL), the future-ready platform for the Office of the CFO, today announces BeyondTheBlack Paris, taking place on Thursday 25 June 2026 at 28 George V, Paris 8. BeyondTheBlack Paris will bring together finance and accounting leaders from across France and the wider EMEA region for a full day dedicated to finance transformation, industry best practice and peer-led learning. As part of BlackLine’s global BeyondTheBlack event series, the Paris event will focus on how finance teams can streamline operations, improve accuracy and unlock greater strategic value through automation and intelligence. The programme will feature keynote sessions from Owen Ryan, CEO of BlackLine, and Philippe Omer-Decugis, General Manager, EMEA, followed by a technology-focused session from Jeremy Ung, CTO, who will unveil exclusive major product announcements while examining the role of AI and innovation across finance and accounting. Attendees will also hear from partners and customers thr
BlackLine Announces BeyondTheBlack London, Bringing Finance Leaders Together to Shape the Future of the Office of the CFO3.3.2026 10:00:00 CET | Press release
BlackLine, Inc. (Nasdaq: BL), the future-ready platform for the Office of the CFO, today announces BeyondTheBlack London, taking place on Tuesday 14 April 2026 at the London Hilton on Park Lane. BeyondTheBlack is BlackLine’s award-winning event series, designed to bring finance and accounting leaders together to explore how modern teams can transform core financial processes, reduce manual work, and operate with greater accuracy, efficiency and intelligence. The London event will convene senior finance professionals, partners and BlackLine executives for a full day of learning, peer-led insight and networking. The agenda will open with plenary sessions from Owen Ryan, CEO of BlackLine, and Philippe Omer-Decugis, General Manager, EMEA, followed by a keynote from Jeremy Ung, CTO, who will share BlackLine’s latest thinking on AI, automation and innovation across the Office of the CFO. Morning sessions will also include an expert partner panel and guest keynote, before attendees move into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom